Shattuck Labs, Inc. Earnings Per Share, Basic and Diluted
Shattuck Labs, Inc. (STTK) reported Earnings Per Share, Basic and Diluted of -$0.28 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-10
- Shattuck Labs, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.28.
- Shattuck Labs, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.31.
- Shattuck Labs, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$1.54.
- Shattuck Labs, Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.86.
- Shattuck Labs, Inc. earnings per share, basic and diluted for fiscal 2020 was -$2.36.
- Shattuck Labs, Inc. earnings per share, basic and diluted for fiscal 2019 was -$3.17.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$0.28 10-Q · filed 2021-05-10 | -$0.59 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1.21 derived: net income ÷ weighted average shares · filed 2022-11-09 | |
| 2020-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$1.02 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$2.36 10-K · filed 2021-03-16 | |
| 2020-09-30 | -$1.54 10-Q · filed 2020-11-13 | -$3.21 10-Q · filed 2020-11-13 | ||
| 2020-03-31 | -$0.86 10-Q · filed 2021-05-10 | -$1.83 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$2.79 derived: net income ÷ weighted average shares · filed 2021-11-09 | |
| 2019-12-31 | -$0.97 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$1.93 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$3.17 10-K · filed 2021-03-16 | |
| 2019-09-30 | -$0.96 10-Q · filed 2020-11-13 | -$2.20 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |